Sault Ste. Marie, Canada Clinical Trials

A listing of Sault Ste. Marie, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

A phase III multi-center, randomized, open-label trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant treatment in patients with HR+/HER2- Early Breast Cancer

Novartis Investigative Site
 (2.2 away) Contact site
  • 211 views
  • 17 Jul, 2021
  • +362 other locations
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or IIA Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)

The purpose of this study is to assess the efficacy and safety of stereotactic body radiotherapy (SBRT) plus pembrolizumab (MK-3475) in the treatment of adult participants with unresected stage I or IIA non-small cell lung cancer (NSCLC). The primary study hypotheses are: SBRT plus pembrolizumab prolongs Event-free Survival (EFS) compared …

mk-3475
lung carcinoma
stereotactic body radiation therapy
pembrolizumab
Sault Area Hospital ( Site 0101)
 (2.2 away) Contact site
  • 121 views
  • 25 Jul, 2021
  • +178 other locations
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

The purpose of this study is to determine the effectiveness of darolutamide as part of adjuvant androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate cancer at very high risk of recurrence.

external beam radiotherapy
neutrophil count
gonadotropin
luteinizing hormone
external beam radiation therapy
Sault Area Hospital - Algoma District Cancer Program
 (2.2 away) Contact site
  • 62 views
  • 25 Jul, 2021
  • +47 other locations
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming …

endocrine therapy
aromatase inhibitor
hormone therapy
tamoxifen
HER2
Algoma District Cancer Program Sault Area Hospital
 (2.2 away) Contact site
  • 591 views
  • 25 Jul, 2021
  • +318 other locations
Fulvestrant and Ipatasertib for Advanced HER-2 Negative and Estrogen Receptor Positive (ER+) Breast Cancer Following Progression on First Line CDK 4/6 Inhibitor and Aromatase Inhibitor

The purpose of this study is to find out whether a new drug, Ipatasertib, can slow the growth of advanced breast cancer when added to standard therapy (Fulvestrant).

aromatase inhibitor
advanced breast cancer
fulvestrant
metastasis
estrogen receptor
Algoma District Cancer Program
 (2.2 away) Contact site
  • 0 views
  • 23 Jul, 2021
  • +13 other locations